P2x3 and/or p2x2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
US-2024400592-A1 · Dec 5, 2024 · US
US9469656B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9469656-B2 |
| Application number | US-201514712341-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 14, 2015 |
| Priority date | May 15, 2014 |
| Publication date | Oct 18, 2016 |
| Grant date | Oct 18, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Largazole analogs, methods of making the same, and methods of using the same, are described.
Opening claim text (preview).
What is claimed is: 1. A compound of Formula XV: wherein: dashed lines represent bonds that may be present or absent; and each X is independently O, N, or NR 1 , wherein R 1 is selected from the group consisting of: methyl, aryl, alkaryl, hydrogen, and ether; and salts, stereoisomers, racemates, prodrugs, solvates, and hydrates thereof.…
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.